These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37839367)
1. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trial. Krause N; Derad C; von Glasenapp B; Riemann-Lorenz K; Temmes H; van de Loo M; Friede T; Asendorf T; Heesen C; Mult Scler Relat Disord; 2023 Nov; 79():105043. PubMed ID: 37839367 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1). Krause N; Riemann-Lorenz K; Steffen T; Rahn AC; Pöttgen J; Stellmann JP; Köpke S; Friede T; Icks A; Vomhof M; Temmes H; van de Loo M; Gold SM; Heesen C BMJ Open; 2021 Feb; 11(2):e041720. PubMed ID: 33593774 [TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a digital lifestyle management intervention (levidex) to improve quality of life in people with multiple sclerosis: results of a randomized controlled trial. Meyer B; Betz LT; Jacob GA; Krause N; Riemann-Lorenz K; Gold SM; Pöttgen J; Heesen C BMC Neurol; 2024 Sep; 24(1):347. PubMed ID: 39285343 [TBL] [Abstract][Full Text] [Related]
6. Acceptability of a digital health application to empower persons with multiple sclerosis with moderate to severe disability: single-arm prospective pilot study. Kutzinski M; Krause N; Riemann-Lorenz K; Meyer B; Heesen C BMC Neurol; 2023 Oct; 23(1):382. PubMed ID: 37872471 [TBL] [Abstract][Full Text] [Related]
7. Health behaviors of people with multiple sclerosis and its associations with MS related outcomes: a German clinical cohort. Goldin K; Riemann-Lorenz K; Daubmann A; Pöttgen J; Krause N; Schröder H; Heesen C Front Neurol; 2023; 14():1172419. PubMed ID: 37780722 [TBL] [Abstract][Full Text] [Related]
8. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review. Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152 [TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic health risks, lifestyle behaviours and quality of life in people diagnosed with early psychosis - A cross-sectional study. Meepring S; Gray R; Li Y; Ho G; Chien WT; Bressington D J Psychiatr Ment Health Nurs; 2022 Aug; 29(4):578-591. PubMed ID: 34854171 [TBL] [Abstract][Full Text] [Related]
11. Baseline engagement with healthy lifestyles and their associations with health outcomes in people with multiple sclerosis enrolled in an online multimodal lifestyle course. Yu M; Neate S; Nag N; Bevens W; Jelinek G; Simpson-Yap S; Davenport RA; Fidao A; Reece J Eur J Neurol; 2024 Oct; 31(10):e16429. PubMed ID: 39109838 [TBL] [Abstract][Full Text] [Related]
12. Engagement with three or more healthy lifestyle behaviours is associated with improved quality of life over 7.5 years in people with multiple sclerosis. Fidao A; Jelinek G; Simpson-Yap S; Neate S; Nag N Eur J Neurol; 2023 Oct; 30(10):3190-3199. PubMed ID: 37338134 [TBL] [Abstract][Full Text] [Related]
13. Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: a randomised controlled feasibility study. Carter AM; Daley AJ; Kesterton SW; Woodroofe NM; Saxton JM; Sharrack B Contemp Clin Trials; 2013 Jul; 35(2):40-7. PubMed ID: 23612222 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors. Marck CH; Neate SL; Taylor KL; Weiland TJ; Jelinek GA PLoS One; 2016; 11(2):e0148573. PubMed ID: 26849357 [TBL] [Abstract][Full Text] [Related]
16. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350 [TBL] [Abstract][Full Text] [Related]
17. Non-communicable disease prevention in Kosovo: quantitative and qualitative assessment of uptake and barriers of an intervention for healthier lifestyles in primary healthcare. Bytyci-Katanolli A; Merten S; Kwiatkowski M; Obas K; Gerold J; Zahorka M; Jerliu N; Ramadani Q; Fota N; Probst-Hensch N BMC Health Serv Res; 2022 May; 22(1):647. PubMed ID: 35568906 [TBL] [Abstract][Full Text] [Related]
18. A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT. Gunn H; Andrade J; Paul L; Miller L; Creanor S; Stevens K; Green C; Ewings P; Barton A; Berrow M; Vickery J; Marshall B; Zajicek J; Freeman J Health Technol Assess; 2019 Jun; 23(27):1-166. PubMed ID: 31217069 [TBL] [Abstract][Full Text] [Related]
19. Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy. Felicetti F; Tommasin S; Petracca M; De Giglio L; Gurreri F; Ianniello A; Nistri R; Pozzilli C; Ruggieri S Front Nutr; 2022; 9():882426. PubMed ID: 35782931 [TBL] [Abstract][Full Text] [Related]
20. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]